Brain, Spine and Nervous System Cancers
Overview
Highlighted VideoThree personal stories describe integrative approaches to malignant brain cancer. From Indigo Rebel Films |
The Ultimate Guide to Cancer: DIY ResearchThis guide from Ralph Moss, PhD, BCCT advisor and leading chronicler of integrative cancer treatments, shows you how to use four of the main tools that doctors use to decide on the best cancer treatments. It will help you learn why some cancer treatments that look good in clinical trials may not work for “real world” patients. It will help you answer two questions that the doctor may be hesitant to answer in the detail you need to decide about treatment:
|
Our goal is to help you live as well as you can for as long as you can using the optimal combination of conventional, complementary and integrative therapies and approaches. Here you'll find resources for brain, spine and nervous system cancers. You can also use the search box in the upper right corner of every page or go to Search Therapy Summaries and search for your cancer.
Learn More
Integrative Approaches and SurgerySurgery may be part of the recommended treatment for this cancer type. We provide helpful information about how integrative approaches can coordinate with surgery on our Integrative Approaches and Surgery page. |
A starting place for the science and conventional therapies:
- National Cancer Institute:
- Cancer.net: Brain Tumor
- Clinical Trials
- A Phase 2 Study of BGJ398 in Patients with Recurrent GBM
- Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study
- Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients with Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Clinical Practice Guidelines
- National Comprehensive Cancer Network:
- Professional Guidelines (Login required)
- Guidelines for Patients: Gliomas
Integrative Programs, Protocols and Medical Systems
For more information about programs and protocols, see our Integrative Programs and Protocols page. |
- Programs and protocols
Advocacy and Support Groups
- National Comprehensive Cancer Network: Advocacy and Support Groups; select brain tumor or another topic of interest from the dropdown menu.
- American Brain Tumor Association: Social & Emotional Support
- National Brain Tumor Society: Resources for Patient and Caregiver Assistance
- Our Brain Tumors Cocktails and Stories
More Information
- National Cancer Institute: Contact Us for Help
Information specialists at the NCI Contact Center are available to help answer your cancer-related questions in English and Spanish whether you are a patient, family member or friend, health care provider, or researcher. We also respond to questions and requests for information about NCI and its programs and provide support in quitting smoking. - Yang W, Warrington NM et al. Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Science Translational Medicine. 2019 Jan 2;11(473). pii: eaao5253. Also see a news article about this study: Washington University School of Medicine. Sex differences identified in deadly brain tumors: tailoring treatment to men, women may improve survival. ScienceDaily. January 2, 2019.
- Musella Foundation:
- ADC Review: Depatuxizumab Mafodotin (ABT-414) Drug Description
- Kast RE, Boockvar JA et al. A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. Oncotarget. 2013 Apr;4(4):502-30.
- Gurdev Parmar and Tina Kaczor: Textbook of Naturopathic Oncology
- Dwight McKee, MD, editor: Clinical Pearls
- Ralph Moss, PhD: The Moss Reports
Related Pages
In the News
- Cell phone use does not increase the risk of brain tumors, study suggests
- CBD reduces glioblastoma’s size, supportive environment in experimental model
- Study explores ketogenic diet and intermittent fasting in patients with brain cancer
- Early findings show new drug could be ‘gamechanging’ for brain cancer treatment
- Use of dexamethasone may decrease the efficacy of immune checkpoint inhibitors in patients with glioblastoma